Abstract
Objective
We conducted a systematic review to evaluate the outcome of macular hole (MH) treatment in eyes with uveitis.
Data source
We searched PubMed and Embase databases from inception through August 15, 2021.
Study selection
We included eyes with MHs secondary to uveitis that were managed medically or underwent pars plana vitrectomy (PPV). We excluded eyes with idiopathic MH and those secondary to causes other than uveitis.
Results
Of 27 articles, we identified 86 eyes with MH secondary to uveitis that received either conservative medical treatment alone or PPV with adequate follow-up. The mean (± SD) age of patients included in this review was 46.6 (± 16.8) years; 60.5% were males. The most common etiology of uveitis was Behçet’s disease (34.6%) and toxoplasmosis (19.7%). The most common anatomical location of uveitis was posterior (59.3%) followed by panuveitis (35.2%). The mean (± SD) baseline LogMAR vision was 1.1 (± 0.5). Conservative medical treatment was employed in 34.9%, while PPV was performed in 65.1% of eyes. Overall, the mean (SD) LogMAR vision improved from 1.1 (± 0.5) at baseline to 0.7 (± 0.5) after treatment. Inflammation-related MHs were closed in 40% of eyes after conservative therapy and in 87.5% of eyes after PPV. Visual improvement occurred in most eyes (83.9%) that had successful closure of their MH.
Conclusions
Visual improvement occurs in most eyes that had successful closure of their inflammation-related MH. Conservative medical control of uveitis may lead to closure of inflammation-related MHs and is an important step prior to surgery, if required. Surgical intervention for inflammation-related MHs is associated with good functional and anatomical results.
Similar content being viewed by others
References
Tomkins-Netzer O, Talat L, Bar A et al (2014) Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology 121:2387–2392
Callaway NF, Gonzalez MA, Yonekawa Y et al (2018) Outcomes of pars plana vitrectomy for macular hole in patients with uveitis. Retina 38:S41–S48
Branson SV, McClafferty BR, Kurup SK (2017) Vitrectomy for epiretinal membranes and macular holes in uveitis patients. J Ocul Pharmacol Ther 33:298–303
Babu K, Mahendradas P (2013) Medical management of uveitis—current trends. Indian J Ophthalmol 61:277–283
Bonnin N, Cornut PL, Chaise F et al (2013) Spontaneous closure of macular holes secondary to posterior uveitis: case series and a literature review. J Ophthalmic Inflamm Infect 3(1):34. https://doi.org/10.1186/1869-5760-3-34
Becker M, Davis J (2005) Vitrectomy in the treatment of uveitis. Am J Ophthalmol 140:1096–1105
Kurup SK, Fine HF, Thomas T (2017) Whether to ignore the macular hole in a uveitic patient: a discussion of the pros and cons of elective macular surgery in a challenging population. Ophthalmic Surg Lasers Imaging Retina 48:956–960
Arana B, Fonollosa A, Artaraz J, Martinez-Berriotxoa A, Martinez-Alday N (2014) Macular hole secondary to toxoplasmic retinochoroiditis. Int Ophthalmol 34:141–143. https://doi.org/10.1007/s10792-013-9754-2
Sen P, Shah H, Geogre A (2019) Inverted flap technique for large macular hole secondary to chronic uveitis. Middle East Afr J Ophthalmol 26:43
Nussenblatt RB (1986) Macular alterations secondary to intraocular inflammatory disease. Ophthalmology 93:984–988
Woo SJ, Yu HG, Chung H (2010) Surgical outcome of vitrectomy for macular hole secondary to uveitis. Acta Ophthalmol 88:e287-288
Tingting Liu HB, Wang X, Gao Y, Wang G, Ma W (2015) Macular abnormalities in Chinese patients with uveitis. Optom Vis Sci 92:858–862
Mizuno M, Fujinami K, Watanabe K, Akiyama K (2015) Macular hole associated with Vogt-Koyanagi-Harada Disease at the acute uveitic stage. Case Rep Ophthalmol 6:328–332
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE (2018) PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467–473. https://doi.org/10.7326/m18-0850
Karthikeya R, Ravani RD, Kakkar P et al (2017) Intravitreal cysticercosis with full thickness macular hole: management outcome and intraoperative optical coherence tomography features. BMJ Case Rep 2017:bcr2016218645. https://doi.org/10.1136/bcr-2016-218645
Buckle M, Majid MA, Lee R, Steeples LR (2017) Full-thickness macular hole: a rare complication of Borreliaburgdorferi neuroretinitis. BMJ Case Rep 2017.https://doi.org/10.1136/bcr-2016-219019
Kobayashi I, Inoue M, Okada AA, Keino H, Wakabayashi T, Hirakata A (2008) Vitreous surgery for macular hole in patients with Vogt-Koyanagi-Harada disease. Clin Experiment Ophthalmol 36:861–864. https://doi.org/10.1111/j.1442-9071.2008.01903.x
Shah S, Manayath GJ, Ranjan R, Venkatapathy N, Kanakath A (2021) Sequential multimodal imaging of isolated necrotic full-thickness macular hole secondary to toxoplasma retinochoroiditis. Am J Ophthalmol Case Rep 23:101193. https://doi.org/10.1016/j.ajoc.2021.101193
Seth A, Raina UK, Thirumalai S, Batta S, Ghosh B (2015) Full-thickness macular hole in Bartonella henselae neuroretinitis in an 11-year-old girl. Oman J Ophthalmol 8:44–46. https://doi.org/10.4103/0974-620x.149866
Doshi S, Gulati M, Pathengay A, Hegde S (2020) Spontaneous closure of macular hole in a case of toxoplasma retinochoroiditis. Indian J Ophthalmol 68:915–916. https://doi.org/10.4103/ijo.IJO_1262_19
Halkiadakis I, Pantelia E, Giannakopoulos N, Koutsandrea C, Markomichelakis NN (2003) Macular hole closure after peribulbar steroid injection. Am J Ophthalmol 136:1165–1167. https://doi.org/10.1016/s0002-9394(03)00668-8
Mesquida M, Pelegrín L, Llorenç V, Espinosa G, Ríos J, Dick AD, Adán A (2013) Pars plana vitrectomy for vitreoretinal complications of Behçet uveitis. Eur J Ophthalmol 23:119–128. https://doi.org/10.5301/ejo.5000194
Sheu SJ, Yang CA (2004) Macular hole in Behcet’s disease. Kaohsiung J Med Sci 20:558–562. https://doi.org/10.1016/s1607-551x(09)70258-x
Sousa DC, Andrade GC, Nascimento H, Maia A, Muccioli C (2021) Macular hole associated with toxoplasmosis: a surgical case series. Retin Cases Brief Rep 15:110–113. https://doi.org/10.1097/icb.0000000000000757
Park UC, Yu HG (2021) Ocular inflammation and choroidal thickness after pars plana vitrectomy in chronic recurrent stage of Vogt-Koyanagi-Harada Disease. Ocul Immunol Inflamm 29:388–395. https://doi.org/10.1080/09273948.2019.1677918
Ucar D, Atalay E, Ozyazgan Y et al (2014) An exceptional case of full-thickness macular hole closure in a patient with Behcet disease. Ocul Immunol Inflamm 22:79–81
Ebrahimi Z, Torkashvand A, Zarei M, Faghihi H, Khalili Pour E, Imani Fooldi M, Ebrahimiadib N (2021) Treatment of inflammatory macular hole: case series and review of literature. Ocul Immunol Inflamm:1-7.https://doi.org/10.1080/09273948.2020.1867871
Elhusseiny AM, Smiddy WE, Flynn HW, Schwartz SG (2019) Case series of recurring spontaneous closure of macular hole. Case Rep Ophthalmol Med 2019:2398342. https://doi.org/10.1155/2019/2398342
Al-Dhibi H, Abouammoh M, Al-Harthi E et al (2011) Macular hole in Behcet’s disease. Indian J Ophthalmol 59:359–362
Tanaka R, Obata R, Sawamura H, Ohtomo K, Kaburaki T (2014) Temporal changes in a giant macular hole formed secondary to toxoplasmic retinochoroiditis. Can J Ophthalmol 49:e115-118. https://doi.org/10.1016/j.jcjo.2014.06.006
Kelly NE, Wendel RT (1991) Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 109:654–659. https://doi.org/10.1001/archopht.1991.01080050068031
Shukla D, Dhawan A (2010) Evolution and management of a post-uveitis macular hole. Ophthalmic Surg Lasers Imaging:1–3.https://doi.org/10.3928/15428877-20100215-47
Gregory ME, Bhatt U, Benskin S, Banerjee S (2009) Bilateral full thickness macular holes in association with serpiginous choroiditis. Ocul Immunol Inflamm 17:328–329. https://doi.org/10.3109/09273940903105128
Kusaka S, Hayashi N, Ohji M, Ikuno Y, Gomi F, Tano Y (2003) Macular hole secondary to fungal endophthalmitis. Arch Ophthalmol 121:732–733. https://doi.org/10.1001/archopht.121.5.732
Mahalingam P, Sambhav K (2013) Surgical outcomes of inverted internal limiting membrane flap technique for large macular hole. Indian J Ophthalmol 61:601–603
Hirano M, Morizane Y, Kawata T et al (2015) Case report: successful closure of a large macular hole secondary to uveitis using the inverted internal limiting membrane flap technique. BMC Ophthalmol 15:83
Shukla D, Dhawan A (2011) Pharmacotherapeutic closure of a uveitic macular hole persisting after vitrectomy. Indian J Ophthalmol 59:335–336
Wu TT, Hong MC (2009) Pars plana vitrectomy with internal limiting membrane removal for a macular hole associated with Behcet’s disease. Eye (Lond) 23:1606–1607
Kirkland KA, Uwaydat SH, Siddiqui MZ, Chancellor JR, Soliman MK, Kurup S, Sallam AB (2020) Outcome of intravitreal dexamethasone implant use in uveitic eyes undergoing pars plana vitrectomy surgery. Ocul Immunol Inflamm:1–6.https://doi.org/10.1080/09273948.2020.1726970
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent to participate
For this type of study, formal consent is not required.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The aim of this topical collection is to provide up-to-date information about macular holes (MHs), discuss novel techniques used to enhance the closure rates of MHs, and describe various approaches for management of challenging cases
Rights and permissions
About this article
Cite this article
Soliman, M.K., Tohamy, D.M., Sallam, A.B. et al. Treatment outcomes of macular holes in the setting of uveitis: a scoping review. Graefes Arch Clin Exp Ophthalmol 260, 2079–2086 (2022). https://doi.org/10.1007/s00417-022-05590-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-022-05590-0